Back to Search

JOSEPH LEONARD, MD

MD

Student in an Organized Health Care Education/Training Program

NPI: 1912757816Individual

Specialties, Licenses & Credentials

Student in an Organized Health Care Education/Training ProgramPrimary

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Research & Publications (20)

Antibody treatment in lymphoma.
PMID 19367250·Clin Adv Hematol Oncol·2009
8-other
New monoclonal antibodies for non-Hodgkin's lymphoma.
PMID 18519407·Ann Oncol·2008
6-review
Targeted treatment and new agents in diffuse large B-cell lymphoma.
PMID 18760704·Semin Hematol·2008
6-review
Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
PMID 18567989·Clin Adv Hematol Oncol·2008
6-review
Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies.
PMID 17530024·Oncogene·2007
6-review
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma.
PMID 17470451·Ann Oncol·2007
3-trial
Proteasome inhibition with bortezomib: a new therapeutic strategy for non-Hodgkin's lymphoma.
PMID 16557600·Int J Cancer·2006
6-review
Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.
PMID 15955901·J Clin Oncol·2005
3-trial
New developments in immunotherapy for non-Hodgkin's lymphoma.
PMID 16091197·Curr Oncol Rep·2005
6-review
Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.
PMID 16110029·J Clin Oncol·2005
3-trial
Targeting CD20 in follicular NHL: novel anti-CD20 therapies, antibody engineering, and the use of radioimmunoconjugates.
PMID 16304400·Hematology Am Soc Hematol Educ Program·2005
8-other
Antibodies in the treatment of lymphoma.
PMID 16163182·Clin Adv Hematol Oncol·2004
8-other
Comparative physical and pharmacologic characteristics of iodine-131 and yttrium-90: implications for radioimmunotherapy for patients with non-Hodgkin's lymphoma.
PMID 12743990·Cancer Invest·2003
4-observational
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma.
PMID 12837807·J Clin Oncol·2003
3-trial
Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab).
PMID 11842393·Semin Oncol·2002
6-review
Effect of methyl iodide on deiodinase activity.
PMID 19519149·Inhal Toxicol·2009
4-observational
Durable complete remissions in HIV-associated Hodgkin lymphoma after treatment with only one cycle of chemotherapy complicated by sepsis.
PMID 19525196·Clin Lymphoma Myeloma·2009
5-case
Metal-directed synthesis of enantiomerially pure dimetallic lanthanide luminescent triple-stranded helicates.
PMID 19601680·J Am Chem Soc·2009
8-other
A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.
PMID 19466965·Br J Haematol·2009
3-trial
Luminescent sensing and formation of mixed f-d metal ion complexes between a Eu(iii)-cyclen-phen conjugate and Cu(ii), Fe(ii), and Co(ii) in buffered aqueous solution.
PMID 19513479·Dalton Trans·2009
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1400 PELHAM PKWY S BLDG 6
BRONX, NY 10461

Location

Practice Location

1400 PELHAM PKWY S BLDG 6, BRONX, NY
(718) 918-5820

Quick Facts

NPI
1912757816
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile